DE602006021162D1 - Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus - Google Patents

Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus

Info

Publication number
DE602006021162D1
DE602006021162D1 DE602006021162T DE602006021162T DE602006021162D1 DE 602006021162 D1 DE602006021162 D1 DE 602006021162D1 DE 602006021162 T DE602006021162 T DE 602006021162T DE 602006021162 T DE602006021162 T DE 602006021162T DE 602006021162 D1 DE602006021162 D1 DE 602006021162D1
Authority
DE
Germany
Prior art keywords
polypeptides
fiv
detecting cat
detecting
weak virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006021162T
Other languages
English (en)
Inventor
Randall Groat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Publication of DE602006021162D1 publication Critical patent/DE602006021162D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602006021162T 2005-03-09 2006-02-22 Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus Active DE602006021162D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/075,480 US7291338B2 (en) 2005-03-09 2005-03-09 Method and device for detecting feline immunodeficiency virus
PCT/US2006/006107 WO2006098849A2 (en) 2005-03-09 2006-02-22 Method and device for detecting feline immunodeficiency virus

Publications (1)

Publication Number Publication Date
DE602006021162D1 true DE602006021162D1 (de) 2011-05-19

Family

ID=36971944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006021162T Active DE602006021162D1 (de) 2005-03-09 2006-02-22 Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus

Country Status (9)

Country Link
US (1) US7291338B2 (de)
EP (1) EP1866330B1 (de)
JP (1) JP2008533006A (de)
AT (1) ATE504596T1 (de)
AU (1) AU2006223631B2 (de)
CA (1) CA2598230A1 (de)
DE (1) DE602006021162D1 (de)
ES (1) ES2363537T3 (de)
WO (1) WO2006098849A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080213910A1 (en) * 2006-10-31 2008-09-04 Gangadhar Jogikalmath Method for blocking non-specific protein binding on a functionalized surface
EP2553452B1 (de) * 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Nachweis des felinen immundefizienzvirus
KR101219505B1 (ko) 2010-05-28 2013-01-31 베트올 (주) 고양이 톡소포자충 감염 진단 방법 및 키트
WO2014055552A1 (en) * 2012-10-03 2014-04-10 Csl Behring Llc A method of purifying proteins
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629783A (en) 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4879212A (en) 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
CA1341439C (en) 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
US4900548A (en) 1987-11-13 1990-02-13 Harvard University Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
CA1335880C (en) 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US5177014A (en) 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
EP1475442A3 (de) * 1989-05-08 2004-11-17 Idexx Laboratories, Inc. Lymphotropische Polypeptide von dem Lentivirus von den T-zellen der Katze
FR2669338A1 (fr) 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
AU667669B2 (en) 1991-06-14 1996-04-04 Idexx Laboratories, Inc. Detection of mammalian immunodeficiency viruses
WO1993001304A1 (en) 1991-07-10 1993-01-21 Synbiotics Corporation Synthetic peptides related to fiv-env proteins
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US5736378A (en) 1991-09-12 1998-04-07 The Scripps Research Institute Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
GB9215232D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
US5462852A (en) 1992-10-28 1995-10-31 The Government Of The United States Of America, As Represented By The Secretary, Dhhs HIV Nucleocapsid protein capture assay and method of use
DE4242475A1 (de) 1992-12-16 1994-06-23 Suspa Compart Ag Führungsbuchse, insbesondere für längenverstellbare Stuhl-Säule und Stuhl-Säule mit derartiger Führungsbuchse
US5576177A (en) 1994-03-09 1996-11-19 St. Jude Children's Research Hospital Bioassay for reverse transcriptase inhibitors
WO1995030019A1 (en) 1994-04-29 1995-11-09 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
FR2721031B1 (fr) 1994-06-09 1996-07-26 Centre Nat Rech Scient Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic.
AU688953B2 (en) 1994-07-25 1998-03-19 Boehringer Mannheim Gmbh Determination of a specific immunoglobulin using multiple antigens
FR2732346B1 (fr) 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5820869A (en) 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5849303A (en) 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US6254872B1 (en) 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
ATE297218T1 (de) 1995-08-25 2005-06-15 Univ Florida Impfstoff gegen mehrere fiv-subtypen
US6077662A (en) 1996-11-27 2000-06-20 Emory University Virus-like particles, methods and immunogenic compositions
US6331616B1 (en) 1997-03-05 2001-12-18 North Carolina State University Nucleic acids obtained from the envelope coding region of feline immunodeficiency virus molecular clone designated JSY3
FR2769916B1 (fr) 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
ATE353563T1 (de) 1997-12-05 2007-03-15 Univ New Mexico Verfahren zur reinigung von hitze-schock peptidkomplexen
US6284253B1 (en) 1998-01-29 2001-09-04 Cornell Research Foundation, Inc. Feline immunodeficiency virus (FIV) nucleotide sequence
US6458528B1 (en) 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
AU6683400A (en) 1999-07-08 2001-01-30 Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
WO2001025188A1 (en) 1999-10-04 2001-04-12 University Of Medicine And Dentistry Of New Jersey Novel carbamates and ureas
FR2828687B1 (fr) 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
KR20060032138A (ko) 2003-05-12 2006-04-14 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 에프아이브이 감염에 대항하여 면역화를 위한 물질 및 방법
JP2007505320A (ja) * 2003-09-11 2007-03-08 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置

Also Published As

Publication number Publication date
JP2008533006A (ja) 2008-08-21
ES2363537T3 (es) 2011-08-08
CA2598230A1 (en) 2006-09-21
AU2006223631B2 (en) 2009-12-17
EP1866330A2 (de) 2007-12-19
EP1866330B1 (de) 2011-04-06
WO2006098849A2 (en) 2006-09-21
ATE504596T1 (de) 2011-04-15
AU2006223631A1 (en) 2006-09-21
WO2006098849A3 (en) 2007-04-19
US20060205923A1 (en) 2006-09-14
US7291338B2 (en) 2007-11-06

Similar Documents

Publication Publication Date Title
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
ATE466108T1 (de) Optoelektronisches detektionssystem
EA201171046A1 (ru) Зонды и праймеры для детектирования вируса чикунгуньи
ATE385259T1 (de) Verfahren zum nachweis von influenza a/b-viren in speichel
WO2008147382A8 (en) Integrated microfluidic assay devices and methods
EA200971124A1 (ru) Множественный анализ образцов крови
CL2011002228A1 (es) Aparato para el analisis integrado de acidos nucleicos en tiempo real, y metodo de detecicion de dichas moleculas.
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
DE602005015299D1 (de) Verfahren, chip, vorrichtung und integriertes system zum nachweis biologischer partikel
BRPI0610092B8 (pt) métodos para a detecção de um analito e de um ácido nucleico em uma amostra, e de sintetização de uma molécula de ácido nucleico ou de análogo de ácido nucleico, kit reagente, uso do mesmo, molécula de ácido nucleico ou de análogo de ácido nucleico e produto associado
DE602006021162D1 (de) Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
ATE441723T1 (de) Verfahren und vorrichtung für den verbesserten nachweis von giftstoffen
BRPI0519354B8 (pt) método para detecção de um anticorpo terapêutico e uso de um anticorpo
ATE443154T1 (de) Vorrichtung und verfahren zur bestimmung und klassifizierung von chemikalien, partikeln, viren und bakterien in fluiden mittels aptamer
ATE537191T1 (de) Protein, verfahren zur proteinimmobilisierung, struktur, biosensor, nukleinsäure, vektor und kit für den nachweis einer zielsubstanz
ATE485060T1 (de) Verfahren zur diagnose von infektionskrankheiten
DE60307337D1 (de) Verfahren zur Identifizierung von Umweltkontaminationen durch Detektion von Enteroviren
DE602005027326D1 (de) Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
DE602004021724D1 (de) Verfahren zum nachweis des felinen immunschwächevirus
MX2010005713A (es) Metodo y kit para detectar virus de diarrea viral bovina en muestras tisulares.
GB0304832D0 (en) Assay method
DK1192469T3 (da) Assay
ATE505730T1 (de) Verfahren zum nachweis einer an einen nukleären rezeptor gebundenen substanz
RU2008126759A (ru) Способ применения комплексной тест-системы иммуноферментного анализа (ифа) для выявления специфических антител к вирусным респираторным инфекциям в биологических жидкостях организма крупного рогатого скота
ATE537446T1 (de) Verfahren zum nachweis von chlamydien in proben